- Home
- ECOR vs MGN Comparison
ECOR vs MGN Comparison
Compare ECOR & MGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- MGN
- Stock Information
- Founded
- ECOR 2005
- MGN 2020
- Country
- ECOR United States
- MGN Malaysia
- Employees
- ECOR N/A
- MGN N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- MGN
- Sector
- ECOR Health Care
- MGN
- Exchange
- ECOR Nasdaq
- MGN Nasdaq
- Market Cap
- ECOR 40.0M
- MGN 43.0M
- IPO Year
- ECOR 2018
- MGN 2025
- Fundamental
- Price
- ECOR $5.09
- MGN $2.12
- Analyst Decision
- ECOR Strong Buy
- MGN
- Analyst Count
- ECOR 2
- MGN 0
- Target Price
- ECOR $25.50
- MGN N/A
- AVG Volume (30 Days)
- ECOR 46.6K
- MGN 878.5K
- Earning Date
- ECOR 11-12-2025
- MGN 10-28-2025
- Dividend Yield
- ECOR N/A
- MGN N/A
- EPS Growth
- ECOR N/A
- MGN N/A
- EPS
- ECOR N/A
- MGN 0.07
- Revenue
- ECOR $27,700,000.00
- MGN $13,484,571.00
- Revenue This Year
- ECOR $24.48
- MGN N/A
- Revenue Next Year
- ECOR $44.35
- MGN N/A
- P/E Ratio
- ECOR N/A
- MGN $32.24
- Revenue Growth
- ECOR 30.16
- MGN N/A
- 52 Week Low
- ECOR $4.16
- MGN $2.01
- 52 Week High
- ECOR $19.49
- MGN $8.63
- Technical
- Relative Strength Index (RSI)
- ECOR 48.99
- MGN N/A
- Support Level
- ECOR $4.80
- MGN N/A
- Resistance Level
- ECOR $5.26
- MGN N/A
- Average True Range (ATR)
- ECOR 0.25
- MGN 0.00
- MACD
- ECOR 0.03
- MGN 0.00
- Stochastic Oscillator
- ECOR 55.17
- MGN 0.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About MGN Megan Holdings Limited Ordinary Shares
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.